| # | Title | Journal | Year | Citations |
|---|
| 1 | Chronic Wound Healing: A Review of Current Management and Treatments | Advances in Therapy | 2017 | 1,247 |
| 2 | Pathogenesis and Treatment of Impaired Wound Healing in Diabetes Mellitus: New Insights | Advances in Therapy | 2014 | 440 |
| 3 | Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis | Advances in Therapy | 2013 | 430 |
| 4 | Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician | Advances in Therapy | 2018 | 424 |
| 5 | Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience | Advances in Therapy | 2017 | 407 |
| 6 | NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk | Advances in Therapy | 2017 | 380 |
| 7 | 25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives | Advances in Therapy | 2016 | 297 |
| 8 | Sepsis: A Review of Advances in Management | Advances in Therapy | 2017 | 276 |
| 9 | Effects of common ophthalmic preservatives on ocular health | Advances in Therapy | 2001 | 257 |
| 10 | Medication adherence and persistence: A comprehensive review | Advances in Therapy | 2005 | 241 |
| 11 | Antibody–Drug Conjugates (ADCs) for Personalized Treatment of Solid Tumors: A Review | Advances in Therapy | 2017 | 227 |
| 12 | A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy | Advances in Therapy | 2011 | 226 |
| 13 | Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension | Advances in Therapy | 2001 | 216 |
| 14 | Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review | Advances in Therapy | 2020 | 206 |
| 15 | Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis | Advances in Therapy | 2011 | 198 |
| 16 | A Review of Chronic Granulomatous Disease | Advances in Therapy | 2017 | 195 |
| 17 | Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease | Advances in Therapy | 2010 | 189 |
| 18 | Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium | Advances in Therapy | 2015 | 187 |
| 19 | Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review | Advances in Therapy | 2020 | 187 |
| 20 | DPP-4 Inhibitors and Lipids: Systematic Review and Meta-Analysis | Advances in Therapy | 2012 | 185 |
| 21 | A Review of Uric Acid, Crystal Deposition Disease, and Gout | Advances in Therapy | 2015 | 184 |
| 22 | Hypothyroidism in Context: Where We’ve Been and Where We’re Going | Advances in Therapy | 2019 | 182 |
| 23 | Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis | Advances in Therapy | 2009 | 175 |
| 24 | Hip Osteoarthritis: Etiopathogenesis and Implications for Management | Advances in Therapy | 2016 | 169 |
| 25 | Quality of Life in Glaucoma: A Review of the Literature | Advances in Therapy | 2016 | 167 |
| 26 | AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme | Advances in Therapy | 2011 | 165 |
| 27 | Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians | Advances in Therapy | 2016 | 165 |
| 28 | Validation of an overactive bladder awareness tool for use in primary care settings | Advances in Therapy | 2005 | 162 |
| 29 | Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain | Advances in Therapy | 2010 | 160 |
| 30 | Managing chronic nonmalignant pain: Overcoming obstacles to the use of opioids | Advances in Therapy | 2000 | 153 |
| 31 | A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies | Advances in Therapy | 2018 | 152 |
| 32 | Prospective, Unmasked Evaluation of the iStent® Inject System for Open-Angle Glaucoma: Synergy Trial | Advances in Therapy | 2014 | 150 |
| 33 | Safety and Tolerability of Empagliflozin in Patients with Type 2 Diabetes: Pooled Analysis of Phase I–III Clinical Trials | Advances in Therapy | 2017 | 150 |
| 34 | Preventing the common cold with a garlic supplement: A double-blind, placebo-controlled survey | Advances in Therapy | 2001 | 146 |
| 35 | Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors | Advances in Therapy | 2019 | 145 |
| 36 | Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR | Advances in Therapy | 2020 | 144 |
| 37 | Body Weight Considerations in the Management of Type 2 Diabetes | Advances in Therapy | 2019 | 139 |
| 38 | The dexamethasone drug delivery system: Indications and evidence | Advances in Therapy | 2011 | 136 |
| 39 | Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells | Advances in Therapy | 2010 | 134 |
| 40 | Incidence, Prevalence, and Survival of Patients with Idiopathic Pulmonary Fibrosis in the UK | Advances in Therapy | 2018 | 134 |
| 41 | Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer | Advances in Therapy | 2008 | 132 |
| 42 | Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site | Advances in Therapy | 2019 | 132 |
| 43 | Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures | Advances in Therapy | 2017 | 131 |
| 44 | A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases | Advances in Therapy | 2015 | 130 |
| 45 | The Seriousness of Chronic Venous Disease: A Review of Real-World Evidence | Advances in Therapy | 2019 | 130 |
| 46 | Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma | Advances in Therapy | 2018 | 129 |
| 47 | A Review of Obinutuzumab (GA101), a Novel Type II Anti-CD20 Monoclonal Antibody, for the Treatment of Patients with B-Cell Malignancies | Advances in Therapy | 2017 | 128 |
| 48 | Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review | Advances in Therapy | 2018 | 128 |
| 49 | The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries | Advances in Therapy | 2015 | 127 |
| 50 | Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma | Advances in Therapy | 2016 | 123 |
